CombiMatrix Molecular Diagnostics, Almac Diagnostics, Rosetta Resolver, Solexa, ExonHit, BioMrieux, Nanogen, FDA, NIH, UPenn | GenomeWeb

CombiMatrix Molecular Diagnostics Receives CLIA Certification

CombiMatrix Molecular Diagnostics has received CLIA certification to operate as a clinical laboratory, the company said last week.

Matt Watson, CEO of CMDX, said his company had been working to establish processes and procedures that would meet quality control and quality assurance standards in line with CLIA since the company was founded in May 2005 (see BAN 5/11/2005).

CMDX is a wholly owned subsidiary of CombiMatrix, which is a unit of Acacia Research.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.